BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Prognosis
218 results:

  • 1. [Gene Profile and Clinical Significance of Concomitant Mutations in CN-AML Patients with
    Zhu J; Kang YF; Gao Y; Wang HW; Hao ZH; Wang HW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):335-341. PubMed ID: 38660833
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Clinical Characteristics and prognosis of Acute Myeloid leukemia Patients with
    Shan RQ; Huang S; Gu ZY; Wang N; Liu DH; Dou LP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):327-334. PubMed ID: 38660832
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Clinical significance of monitoring NUP98::NSD1 fusion genes before and after allogeneic hematopoietic stem cell transplantation].
    Shang YK; Pan XA; Chang YJ; Qin YQ; Wang Y; Yan CH; Sun YQ; Huang XJ; Zhao XS
    Zhonghua Xue Ye Xue Za Zhi; 2023 Dec; 44(12):1010-1015. PubMed ID: 38503524
    [No Abstract]    [Full Text] [Related]  

  • 4. Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
    Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S
    BMC Cancer; 2024 Mar; 24(1):325. PubMed ID: 38459434
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [The Correlation of Gene Mutation and Clinical Characteristics in Patients with Myelodysplastic Syndrome and Prognostic Analysis].
    Zhang WW; Zhang YL; Ren CC; Wu TK; Liu B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):176-183. PubMed ID: 38387918
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic impact of peripheral blood wt1 mRNA dynamics in patients with acute myeloid leukemia treated with venetoclax combination therapy.
    Sato H; Kobayashi T; Kameoka Y; Teshima K; Watanabe A; Yamada M; Yamashita T; Noguchi S; Michisita Y; Fujishima N; Kuroki J; Takahashi N
    Int J Clin Oncol; 2024 Apr; 29(4):481-492. PubMed ID: 38334897
    [TBL] [Abstract] [Full Text] [Related]  

  • 7.
    Choi YJ; Min YK; Lee ST; Choi JR; Shin S
    Ann Lab Med; 2024 Jul; 44(4):335-342. PubMed ID: 38145892
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical characteristics and prognostic factors analysis of core binding factor acute myeloid leukemia in real world.
    Zhai Y; Wang Q; Ji L; Ren H; Dong Y; Yang F; Yin Y; Liang Z; Wang Q; Liu W; Mei Y; Zhang L; Li Y
    Cancer Med; 2023 Dec; 12(24):21592-21604. PubMed ID: 38062912
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical whole-genome sequencing and FISH identify two different fusion partners for NUP98 in a patient with acute myeloid leukemia: A case report.
    Mojarad BA; Crees ZD; Schroeder MC; Xiang Z; Vader J; Sina J; Jacoby M; Frater JL; Duncavage EJ; Spencer DH; Lavine K; Neidich JA; Amarillo I
    Cancer Genet; 2024 Jan; 280-281():1-5. PubMed ID: 38056049
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical significance of wt1 in the evaluation of therapeutic effect and prognosis of non-M3 acute myeloid leukemia.
    Yu T; Zhan Q; Yan X; Luo X; Wang X; Tang X; Zhang H; Yang Z; Chen J; Liu L; Wang L
    Cancer Biol Ther; 2023 Dec; 24(1):2285801. PubMed ID: 38031921
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Wilms' tumor gene 1 in hematological malignancies: friend or foe?
    Wu J; Yan H; Xiang C
    Hematology; 2023 Dec; 28(1):2254557. PubMed ID: 37668240
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [High-Throughput Sequencing Technology for Detection of Gene Mutations in Myeloid Malignancies and Its Clinical Prognostic Significance].
    Ouyang M; Jiang B; Zhang MX; Hu WQ; Shi L; Liu JX; Zhang YY; Wang CJ; Wang F; Zhang Y; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):992-998. PubMed ID: 37551467
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic value of combined wt1 and multiparameter flow cytometry assessment for measurable residual disease after induction in non-APL acute myeloid leukemia.
    Ding Y; Liu Z; Wang H; Xiong S; Zhai Z
    Scand J Clin Lab Invest; 2023 Sep; 83(5):340-347. PubMed ID: 37355341
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic value of the WT-1 gene combined with recurrent cytogenetic genes in acute myeloid leukemia.
    Zhang Q; Liu L; Yan H; Ren X; Zhou M; Xiong S; Wang H; Tao Q; Zhai Z
    Immunogenetics; 2023 Aug; 75(4):395-401. PubMed ID: 37347248
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Immunoreactivity to wt1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding wt1 polypeptide.
    Naoe T; Saito A; Hosono N; Kasahara S; Muto H; Hatano K; Ogura M; Masunari T; Tanaka M; Usuki K; Ishikawa Y; Ando K; Kondo Y; Takagi Y; Takada S; Ishikawa M; Choi I; Sano A; Nagai H
    Cancer Immunol Immunother; 2023 Aug; 72(8):2865-2871. PubMed ID: 37093243
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A global study for acute myeloid leukemia with RARG rearrangement.
    Zhu HH; Qin YZ; Zhang ZL; Liu YJ; Wen LJ; You MJ; Zhang C; Such E; Luo H; Yuan HJ; Zhou HS; Liu HX; Xu R; Li J; Li JH; Hao JP; Jin J; Yu L; Zhang JY; Liu LP; Zhang LP; Huang RB; Shen SH; Gao SJ; Wang W; Yan XJ; Zhang XY; Du X; Chu XX; Yu YF; Wang Y; Mi YC; Lu Y; Cai Z; Su Z; Taussig DC; MacMahon S; Ball ED; Wang HY; Welch JS; Yin CC; Borthakur G; Sanz MA; Kantarjian HM; Huang JY; Hu J; Chen SN
    Blood Adv; 2023 Jul; 7(13):2972-2982. PubMed ID: 36799929
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01.
    Hosono N; Chi S; Yamauchi T; Fukushima K; Shibayama H; Katagiri S; Gotoh A; Eguchi M; Morishita T; Ogasawara R; Kondo T; Yanada M; Yamamoto K; Kobayashi T; Kuroda J; Usuki K; Utsu Y; Yoshimitsu M; Ishitsuka K; Ono T; Takahashi N; Iyama S; Kojima K; Nakamura Y; Fukuhara S; Izutsu K; Abutani H; Yamauchi N; Yuda J; Minami Y;
    Cancer Sci; 2023 May; 114(5):2098-2108. PubMed ID: 36793248
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Restratifying the prognosis of acute myeloid leukemia patients with CEBPA double mutations based on CSF3R mutations and measurable residual disease].
    Su L; Tan YH; Lin H; Han W; Yang YP; Liu XL; Sun JN; Liu QJ; Gao SJ
    Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):1021-1027. PubMed ID: 36709108
    [No Abstract]    [Full Text] [Related]  

  • 19. UBTF-internal tandem duplication as a novel poor prognostic factor in pediatric acute myeloid leukemia.
    Kaburagi T; Shiba N; Yamato G; Yoshida K; Tabuchi K; Ohki K; Ishikita E; Hara Y; Shiraishi Y; Kawasaki H; Sotomatsu M; Takizawa T; Taki T; Kiyokawa N; Tomizawa D; Horibe K; Miyano S; Taga T; Adachi S; Ogawa S; Hayashi Y
    Genes Chromosomes Cancer; 2023 Apr; 62(4):202-209. PubMed ID: 36448876
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genomic Landscape of Mixed-Phenotype Acute leukemia.
    Hennawi M; Pakasticali N; Tashkandi H; Hussaini M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232559
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.